- Home
- STHO vs CADL Comparison
STHO vs CADL Comparison
Compare STHO & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STHO
- CADL
- Stock Information
- Founded
- STHO N/A
- CADL 1999
- Country
- STHO United States
- CADL United States
- Employees
- STHO N/A
- CADL N/A
- Industry
- STHO Real Estate
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- STHO Real Estate
- CADL Health Care
- Exchange
- STHO Nasdaq
- CADL Nasdaq
- Market Cap
- STHO 153.3M
- CADL 159.1M
- IPO Year
- STHO N/A
- CADL 2021
- Fundamental
- Price
- STHO $9.63
- CADL $8.75
- Analyst Decision
- STHO
- CADL Strong Buy
- Analyst Count
- STHO 0
- CADL 1
- Target Price
- STHO N/A
- CADL $19.00
- AVG Volume (30 Days)
- STHO 77.6K
- CADL 9.7M
- Earning Date
- STHO 11-05-2024
- CADL 11-14-2024
- Dividend Yield
- STHO N/A
- CADL N/A
- EPS Growth
- STHO N/A
- CADL N/A
- EPS
- STHO 6.15
- CADL N/A
- Revenue
- STHO $117,752,000.00
- CADL N/A
- Revenue This Year
- STHO N/A
- CADL N/A
- Revenue Next Year
- STHO N/A
- CADL N/A
- P/E Ratio
- STHO $1.51
- CADL N/A
- Revenue Growth
- STHO 13.35
- CADL N/A
- 52 Week Low
- STHO $9.23
- CADL $1.08
- 52 Week High
- STHO $15.31
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- STHO 18.97
- CADL 68.05
- Support Level
- STHO $10.06
- CADL $5.90
- Resistance Level
- STHO $10.47
- CADL $7.28
- Average True Range (ATR)
- STHO 0.32
- CADL 1.61
- MACD
- STHO -0.08
- CADL 0.37
- Stochastic Oscillator
- STHO 5.77
- CADL 55.04
About STHO Star Holdings Shares of Beneficial Interest
Star Holdings engages in non-ground lease-related businesses, including real estate finance, operating properties, and land and development. Its portfolio is comprised of its interests in Asbury and Magnolia Green residential development projects, a portfolio of commercial real estate properties, and loans that are being marketed for sale. It focuses on realizing value for shareholders from the legacy portfolio by maximizing cash flows through active asset management and asset sales.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.